Written resources

Listed below are our written resources.

 Indicates a resource containing technical content written for a health professional audience.

Most of these resources are PDF files.  Click the Adobe Reader image to visit the Adobe website and download the free PDF file viewer software  .

To search for a particular written resource, use the search box below. 


Concerns and questions

  • Aluminium in vaccines Factsheet (121.83 KB)
  • The facts about childhood vaccines Factsheet (345.96 KB)
  • Thimerosal: What you should know Factsheet (192.65 KB)
  • Vaccine ingredients Factsheet (302.26 KB)
  • Adverse events following immunisation

  • Anaphylaxis and vaccination Factsheet (497.81 KB)
  • Health Professionals
  • Hyperventilation Factsheet (244.94 KB)
  • Health Professionals

    Cold chain

  • *UPDATED* The essential data logger Factsheet (106.79 KB)
  • Health Professionals

    A clinic based quality tool to support you in maintaining high cold chain standards. The guide enables providers to have instant access to temperature-recording charts at the refrigerator site, use the trouble shooting tips for cold chain problems, have a self audit tool to check your clinic is on target for excellence, keep track of your clinic’s cold chain history and use for orientation of new staff.

    Health Professionals

    The National Standards for Vaccine Storage and Transportation for Immunisation Providers 2017, describes the standards and outlines the requirements for providers to achieve these standards. These standards supersede the National Guidelines for Vaccine Storage and Distribution 2012 and the cold chain information in the Immunisation Handbook 2014.

    Health Professionals

    This fact sheet summarises the most important requirements for maintenance of the vaccine cold chain.

  • Vaccine Register Forms/Schedules (304 KB)
  • Health Professionals

    A template for an easy to use Vaccine Register.

    Ministry of Health faxes

  • Immunisation Update April 2017 Ministry Fax (233.09 KB)
  • Health Professionals
  • Immunisation Update February 2017 Ministry Fax (160.31 KB)
  • Health Professionals
  • Immunisation Update December 2016 Ministry Fax (218.78 KB)
  • Health Professionals
  • Immunisation Update September 2016 Ministry Fax (131.03 KB)
  • Health Professionals
  • Immunisation Update August 2016 Ministry Fax (172.33 KB)
  • Health Professionals

    Reports about immunisation

    In 2009 the Institute of Medicine was tasked, by the Health Resources and Services Administration in the U.S., to convene a committee of experts to review the epidemiologic, clinical, and biological evidence regarding adverse health events associated with specific vaccines including varicella zoster vaccine; influenza vaccines; hepatitis B vaccine; human papillomavirus vaccine (HPV); tetanus toxoid-containing vaccines other than those containing the whole cell pertussis component; measles, mumps, and rubella vaccines; hepatitis A vaccine; and meningococcal vaccines. The focus was only on the assessment of risk of vaccines. The prepublication copy: uncorrected proof is available on line. (Institute of Medicine of the National Academies, 25 August 2011)

    Following on from the Adverse effects of vaccines: Evidence and causality report, the Institute of Medicine was tasked, by the Department of Health and Human Services in the U.S., to convene a committee of experts to identify scientific findings and stakeholder concerns about the safety of the current U.S. childhood immunisation schedule and identify research approaches, methodologies, and study designs that could inform this question. The prepublication copy: uncorrected proof is available on line. (Institute of Medicine of the National Academies, 16 January 2013)

    Prepared by the Health Quality & Safety Commission for the Child and Youth Mortality Review Committee, the report emphasises the need for existing immunisation programmes to reduce the risk of pertussis in infants, especially those who are Maori, Pacific or under 3 months of age. The report also establishes the need for strategies to raise awareness of the maternal Tdap immunisation in the third trimester and to improve access to and timely administration of the first three infant immunisation events, particularly for Maori and Pacific infants for whom significant equity issues were identified.

    Health Professionals

    In April 2015 the Ministry of Health held a Workshop at the University of Auckland to bring together expertise and those with experience from this epidemic to discuss pertussis disease control strategies and a consistent approach for New Zealand. Gains have been made in the infant primary immunisation series, but pertussis is still a major public health issue. The Ministry of Health wanted to assess the available data and strategies with the aim of minimising the impact of future outbreaks on those most vulnerable. The Ministry will use the recommendations from the Workshop to develop a consistent approach to pertussis control in New Zealand.

    Health Professionals

    The recommendations of this report, written by Tim Corbett and funded by GlaxoSmithKline, are aimed at increasing the level of comfort whānau experience in General Practice through proactive, whānau based communication and service enhancement approaches.